“We continue to view HEXO as one of a few companies that combine large-scale, low-cost production with strong product development/commercialization capabilities,” says Stanley. “This makes it an ideal target for would-be strategic investors/acquirers from other industries (e.g. alcohol/tobacco/pharmaceutical, etc). Today’s NYSE announcement (and next week’s actual listing) could help put HEXO on additional radar screens, for both strategic and financial investors.”
Market Data 
Markets 
